![Dan Cooper](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Dan Cooper
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Apricity Health LLC
![]() Apricity Health LLC Miscellaneous Commercial ServicesCommercial Services Apricity Health LLC is a digital health company that aims to bridge the gap between academic specialty care and real-world practice. The company is based in Houston, TX. Apricity Health is committed to disseminating clinical expertise to benefit patients everywhere, especially those without access to subspecialty care. Apricity Health develops digital solutions to make novel life-saving cancer therapies safer, better, and more accessible to patients. The company was founded by world-renowned physician scientists in cancer and immuno-oncology, including Keith T. Flaherty, James Allison, Lynda Chin, and Padmanee Sharma. Lynda Chin has been the CEO since incorporation.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dan Cooper
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
The Broad Institute, Inc.
![]() The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
Metamark Genetics, Inc.
![]() Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Founder | |
Dana-Farber Cancer Institute, Inc.
![]() Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
The University of Texas at Austin | College/University | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 8 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Health Services | 3 |
Operativ
Corporate Officer/Principal | 4 |
Founder | 3 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Lynda Chin | 8 |
- Börse
- Insiders
- Dan Cooper
- Unternehmensverbindungen